wire - news in brief

« BACK

Business/Economics



Results 1 - 50 of 380.
1 2 3 4 5 8 Next »

Medicine/Pharmacology - Business/Economics
07.12.2017
Medicine/Pharmacology - Business/Economics
30.10.2017
Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio
Novartis to acquire Advanced Accelerator Applications pending outcome of tender offer and works council consultation   Acquisition would add Lutathera , a first-in-class RadioLigand Therapy (RLT) app
Medicine/Pharmacology - Business/Economics
27.10.2017
Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review
Comprehensive data package demonstrates that Sandoz biosimilar pegfilgrastim matches the reference biologic in terms of safety, efficacy and quality Pegfilgrastim is a long-acting version of oncology
Business/Economics - Medicine/Pharmacology
24.10.2017
Novartis delivered growth on top and bottom line in all divisions in Q3
Net sales grew 2% (cc , +2% USD), with growth in all divisions: Cosentyx (USD 556 million, +83% cc) showed strong growth across all indications Entresto (USD 128 million, +138% cc) grew driven by imp
Business/Economics - Environment/Sustainable Development
23.10.2017
First step towards climate-aligned financial flows
Bern, 23.10.2017 - In the context of the Paris Agreement, Swiss pension funds and insurance companies were invited by the Federal Office for the Environment FOEN and the State Secretariat for International Financial SIF to test the climate compatibility of their portfolios.
Business/Economics - Environment/Sustainable Development
20.10.2017
Physics/Materials Science - Business/Economics
05.10.2017
Environment/Sustainable Development - Business/Economics
02.10.2017
New professorship position for climate and environmental economics has been filled
New professorship position for climate and environmental economics has been filled
Media releases, information for representatives of the media Media Relations (E) The University of Bern has created a professorship for climate and environmental economics, which can now be expanded thanks to the involvement of the Mercator Foundation Switzerland and the Gebäudeversicherung Bern.
Business/Economics - Environment/Sustainable Development
26.09.2017
Where to play: a practical guide for running your tech business
Where to play: a practical guide for running your tech business
The world's leading researcher in entrepreneurship and EPFL Vice-President for Innovation, Marc Gruber, along with co-author Sharon Tal, have written the book "Where to play", a practical strategy th
Medicine/Pharmacology - Business/Economics
04.09.2017
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018
Basel, September 4, 2017 - Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position.
Business/Economics
03.09.2017
Huge interest in the world of data
Big data, digitalisation, artificial intelligence, Internet of Things - these terms are on everybody's lips these days, but what exactly do they mean?
Medicine/Pharmacology - Business/Economics
31.08.2017
Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress
Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress Data from 18 approved and investigational cancer medicines to be presented at ESMO 2017 Results for Zelboraf (vemurafenib) as an adjuvant treatment for BRAF V600 mutation-positive melanoma to feature in the ESMO Presidential Symposium New data from phase III ALEX and ALUR studies provide additional evidence supporting the use o
Business/Economics - Computer Science/Telecom
29.08.2017
The creative data interpreters
The creative data interpreters
The ETH spin-off SpinningBytes programs software that uses machine learning not only to analyse but also to understand huge amounts of data. It enables customised solutions to be developed for numerous IT problems, and allows new insights to be gained from previously unused data. It all began a few years ago: Mark Cieliebak, Martin Jaggi and Fatih Uzdilli were computer science researchers at ETH and Zurich University of Applied Sciences (ZHAW), and published their technologies in scientific papers.
Medicine/Pharmacology - Business/Economics
24.08.2017
Novartis appoints Bertrand Bodson as Chief Digital Officer
New leader to drive the digital transformation Novartis has embarked upon Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief Digital Officer, reporting to Joseph Jimenez, CEO of Novartis.
Medicine/Pharmacology - Business/Economics
21.08.2017
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria
Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission   KAF156 is first compound fro
Environment/Sustainable Development - Business/Economics
16.08.2017
Online campaign against invasive plants
Online campaign against invasive plants
Neophytes - invasive plants that are alien to the region - are a huge burden on the public purse. The ETH spin-off "In-Finitude" has set up a new online platform right on time for the growing season.
Business/Economics - Administration/Government
15.08.2017
The smart grid analysts
The smart grid analysts
ETH spin-off Adaptricity has developed a piece of software that can be used to analyse the increasingly intelligent power grids.
Medicine/Pharmacology - Business/Economics
25.07.2017
Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries
Expanded partnership to help "even the odds" of survival for children with cancer in the Philippines, Myanmar, Mexico and Ghana In developed countries, the survival rate for childhood cancer is 80%,
Business/Economics - Medicine/Pharmacology
18.07.2017
Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products
Net sales in line with prior year (0% cc , -2% USD), as growth drivers offset Gleevec/Glivec Gx impact: Cosentyx (USD 490 million, +90% cc) continues strong growth in all three indications Entresto (U
Computer Science/Telecom - Business/Economics
27.06.2017
More security in cyberspace
More security in cyberspace
At yesterday's Cyber Risks Summit at ETH Zurich, international experts discussed and presented the latest scientific and technological approaches for effectively protecting society from the dangers of cyberspace.
Earth Sciences - Business/Economics
16.06.2017
A new view of the world
A new view of the world
The Swiss World Atlas has been published in a completely revised new edition. In addition to the usual topographic relief maps, it also contains maps on current global issues such as the environment, energy and conflicts. Since 1910, the Swiss World Atlas has accompanied generations of secondary school pupils through their geography lessons, conveying not only a comprehensive picture of the earth, but also the specific geography of Switzerland.
Physics/Materials Science - Business/Economics
14.06.2017
From the garage to the world
In 1999, PSI researchers founded the spin-off firm SwissNeutronics. Today the company has a staff of 15, sells high-precision components to research institutions all over the world, and still is based in the small town of Klingnau - not far from PSI.
Medicine/Pharmacology - Business/Economics
09.06.2017
Hybrid membrane creates a stir on the global market
Hybrid membrane creates a stir on the global market
ETH Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty have developed a filter membrane that efficiently removes heavy metals and other toxic substances from water. Strong demand for the new technology has encouraged them to set up a new ETH spin-off, BluAct Technologies. The news story made a big splash: in January 2016 ETH researchers Professor Raffaele Mezzenga and his senior researcher Sreenath Bolisetty published a study about an innovative type of membrane developed in their laboratory.
Business/Economics - Environment/Sustainable Development
02.06.2017
Emissions trading scheme: acquisition of aviation data in 2018
Bern, 02.06.2017 - The integration of greenhouse gas emissions from the aviation sector into the emissions trading scheme (ETS) is a necessary step in order to link the Swiss and European schemes.
Medicine/Pharmacology - Business/Economics
31.05.2017
At the Meet Novartis Management investor event, Novartis highlights focus on innovation and productivity; expects the next growth phase to begin in 2018
At the Meet Novartis Management investor event, Novartis highlights focus on innovation and productivity; expects the next growth phase to begin in 2018 Building depth across key therapeutic areas wi
Physics/Materials Science - Business/Economics
29.05.2017
To the limits of the feasible
First, the engineers and the physicists had to find each other. Then, however, the company Daetwyler built the undulators for the free-electron X-ray laser SwissFEL of the Paul Scherrer Institute PSI as precisely as was possible: to one-tenth of the width of a hair.
Environment/Sustainable Development - Business/Economics
26.05.2017
Natural disasters and climate-related risks: Switzerland appeals for closer links between disaster risk reduction, climate change and development cooperation
Natural disasters and climate-related risks: Switzerland appeals for closer links between disaster risk reduction, climate change and development cooperation Bern, 26.05.2017 - Natural disasters and climate-related risks threaten to reverse hard-won gains in development.
Medicine/Pharmacology - Business/Economics
04.05.2017
Novartis exercises exclusive option agreement with Conatus for the treatment of NASH
Exclusive license for emricasan supports rapidly growing development portfolio in chronic liver diseases, including NASH   Conatus has initiated the Phase IIb ENCORE-LF clinical trial with emricasan in NASH.
Environment/Sustainable Development - Business/Economics
27.04.2017
Publication of Annual and Sustainability Reports
Publication of Annual and Sustainability Reports
The ETH Zurich 2016 Annual Report provides an overview of the most important achievements, developments and events at the University over the past year, and is published alongside the 2015/2016 Sustainability Report.
Medicine/Pharmacology - Business/Economics
26.04.2017
Alcon announces EU launch of CyPass Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma
Alcon announces EU launch of CyPass Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma Now available in the UK, G
Business/Economics - Medicine/Pharmacology
25.04.2017
Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued Net sales grew 2% (cc, -1
Computer Science/Telecom - Business/Economics
20.04.2017
Sounds provide a safer login
Sounds provide a safer login
A start-up formed by a group of IT specialists at ETH has come up with a simple and user-friendly way to enhance network security.
Medicine/Pharmacology - Business/Economics
18.04.2017
Novartis expands development programs for NASH through clinical collaboration with Allergan
Phase IIb clinical trial to evaluate a combination of a Novartis FXR agonist and Allergan's cenicriviroc for NASH, a progressive  form of non-alcoholic fatty liver disease   There are currently no ap
Business/Economics
13.04.2017
Medicine/Pharmacology - Business/Economics
06.04.2017
Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Novartis exercises an option to in-license ECF843, a recombinant form of human lubricin from Lubris LLC, for ophthalmic indications worldwide (outside Europe) Dry eye is an area with high unmet medic
Physics/Materials Science - Business/Economics
28.03.2017
Dominique Derome new Head of Laboratory
Dominique Derome new Head of Laboratory
On 1 April 2017, Dominique Derome will become the new Head of the Laboratory for Multiscale Studies in Building Physics.
Earth Sciences - Business/Economics
27.03.2017
Archival photos offer research value
Archival photos offer research value
A crowdmapping project developed by EPFL and HEIG-VD gives volunteers the chance to compare the Switzerland of the 1960s with that of today through archival photos.
Medicine/Pharmacology - Business/Economics
26.03.2017
Business/Economics - Environment/Sustainable Development
03.03.2017
Environmental aspects in financial market policy: Federal Council is informed of progress made
Bern, 03.03.2017 - Sustainability is important also for the financial markets.
Business/Economics - Careers/Employment
28.02.2017
Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting
Shareholders approve 20 th consecutive dividend increase to CHF 2.75 (+2%) per share for 2016; representing a 3.5% yield and approximately 69% payout of free cash flow   Dr. Joer
Environment/Sustainable Development - Business/Economics
22.02.2017
2nd edition of the Swiss Cleantech
2nd edition of the Swiss Cleantech
Six years after it first appeared, the second edition of the Swiss Cleantech Report was unveiled today at a press conference in Zurich.
Business/Economics - Environment/Sustainable Development
22.02.2017
Reduction of energy consumption and CO2 emissions: promotion or steering?
Policy interventions to reduce energy consumption and CO2 emissions have a variety of effects on the economy and on households.
Business/Economics
13.02.2017
Financial windfall for young scientists
Financial windfall for young scientists
On February 2nd the EU approved Empa's «COFUND» application for financial support to the tune of more than ‘3.5 million, thereby securing partial funding for 50 post-doc positions at Empa over the next five years within the framework of the EU's Marie Sk'odowska-Curie actions.
Environment/Sustainable Development - Business/Economics
01.02.2017
User feedback is essential, especially for complex technology
User feedback is essential, especially for complex technology
Environmentally friendly, low-carbon energy technologies are needed to achieve global climate targets.
1 2 3 4 5 8 Next »